Navigation Links
Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Date:5/17/2011

ex (NIH-CPSI) scale, which measures symptoms and impact on quality of life (-12.1 +/- 9.3 vs. -8.5 +/- 7.2; P=0.0224).  Statistically significant treatment effects were seen with RAPAFLO(R) 4 mg on the NIH-CPSI scale evaluating urinary symptoms (–2.2 +/- 2.7 vs –1.3 +/- 3.0; P=.0102). Decreases in NIH-CPSI scores with RAPAFLO(R) 8 mg did not provide any additional therapeutic benefit compared to the 4 mg dose.  

In addition, patients treated with RAPAFLO(R) 4 mg showed significantly better results relative to placebo on the physical component of another widely accepted evaluation tool, the 12-Item Short Form Health Survey (SF-12) developed to study patients with chronic conditions (4.2 +/- 8.1 vs 1.7 +/- 9.0; P=.049). In a global response assessment (GRA), 56 percent of patients treated with RAPAFLO(R) 4 mg versus 29 percent of patients receiving placebo reported moderate or marked improvement (P= 0.0069). An increase in dose to 8 mg resulted in no incremental increased effect.

Safety Findings

Overall, one in three (33.1%) of men in the study experienced a treatment-related adverse event (AE).  The incidences of drug-related AEs were similar for RAPAFLO(R) 4 mg and placebo, and included: dizziness (1.9%, 4 mg; 8.9%, 8 mg; 7.4%, placebo);  headache (0, 4 mg; 4.4%, 8 mg; 1.9%, placebo); nasal congestion (3.8%, 4 mg; 6.7%, 8 mg; 0, placebo); and decreased libido (1.9%, 4 mg; 2.2%, 8 mg; 1.9%, placebo).  The most common adverse event was retrograde ejaculation.  More men treated with RAPAFLO(R) versus placebo experienced retrograde ejaculation (26.9%, 4 mg; 40%, 8 mg; 1.9%, placebo).  Retrograde ejaculation, or an orgasm with reduced semen, is an expected and reversible effect of selective alpha blockers and thought to be a direct reflection of the product's selective binding properties.  Discontinuation rates due to a drug-related adverse event were 5.8 percent f
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Watson Confirms Renvela® Patent Challenge
2. Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid
3. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
4. Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights
5. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
6. Vanda Pharmaceuticals Reports First Quarter 2011 Results
7. MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results
8. Anadys Pharmaceuticals to Report First Quarter 2011 Financial Results
9. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results
10. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2011 Financial Results
11. Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Sales Horizons, a ... its online sales training course – Mastering the ... sales performance. , Drawn from proven sales training programs ... Mastering the Complex Sale online sales training course is ... who has face-to-face contact with customers, like technical support, ...
(Date:7/30/2014)... 30, 2014 W. R. Grace ... of the REVELERIS® Prep purification system , ... chromatographers, and other researchers to perform both flash ... unit. , With the REVELERIS® Prep purification system, ... chromatography modes with a simple touch of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears ... American Academy of Dermatology (Academy) in an effort to ... Chicago Bears will host free SPOT me™ skin cancer ... 2 at Soldier Field. SPOT me™ is an ... about the dangers and risks of skin cancer, and ...
(Date:7/30/2014)... Selexis SA , a serial innovation company ... cell line development, announced today new data from the ... at the 10th Annual Cell Line Development and ... 2014 at the Double Tree by Hilton Berkeley Marina ... be presented during an oral presentation: , Title: Genome ...
Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Grace Launches New REVELERIS® Prep Purification System 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... 21, 2011 Reportlinker.com announces that a new ... catalogue: Global Angiongenesis Inhibitors ... http://www.reportlinker.com/p0459142/Global-Angiongenesis-Inhibitors-and-Stimulators-Industry.html This report analyzes ... Stimulators in US$ Million by the following ...
... Chairman of the Board of Directors of the Pittsburgh ... and customized company formation and business growth services to ... Manzetti and the Pittsburgh Life Sciences Greenhouse for being ... category winner at the 2011 Pennsylvania Technology Awards Gala ...
... announces that a new market research report is available ... http://www.reportlinker.com/p098235/Global-Biochips-Industry.html This ... Million by the following product segments - DNA Chips, ... are provided for the period 2007 through 2015. Also, ...
Cached Biology Technology:Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 2Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 3Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 4Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 5Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 6Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 7Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 8Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 9Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 10Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 11Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 12Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 13Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 14Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 15Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 16Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry 17John W. Manzetti and the Pittsburgh Life Sciences Greenhouse Recognized as 2011 Outstanding Leader in Technology 2Reportlinker Adds Global Biochips Industry 2Reportlinker Adds Global Biochips Industry 3Reportlinker Adds Global Biochips Industry 4Reportlinker Adds Global Biochips Industry 5Reportlinker Adds Global Biochips Industry 6Reportlinker Adds Global Biochips Industry 7Reportlinker Adds Global Biochips Industry 8Reportlinker Adds Global Biochips Industry 9Reportlinker Adds Global Biochips Industry 10Reportlinker Adds Global Biochips Industry 11Reportlinker Adds Global Biochips Industry 12Reportlinker Adds Global Biochips Industry 13Reportlinker Adds Global Biochips Industry 14Reportlinker Adds Global Biochips Industry 15Reportlinker Adds Global Biochips Industry 16
(Date:7/30/2014)... is a straight line, and now Harvard researchers have ... to heart. , Though competition among individual sperm ... for the chance to fertilize the egg, Harvard scientists ... allow them to take a straighter path to potential ... Fisher, a post-doctoral student working in the lab of ...
(Date:7/30/2014)... female baboons suggests that the route to a higher rank ... lots of supportive sisters. , A female baboon,s social status ... rank of her mother - the higher the mother is ... dominance rank in female baboons is thought to be determined ... good spot in the pecking order, whereas females born to ...
(Date:7/30/2014)... NexID Biometrics , a leading ... for the biometric authentication industry, has recently joined ... authentication with standards for strong authentication. According to ... to join FIDO Alliance stems from NexID,s mission ... We believe the FIDO Alliance is a key ...
Breaking Biology News(10 mins):When cooperation counts 2When cooperation counts 3Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3NexID Biometrics Joins the FIDO Alliance 2
... from the leading cause of blindness in western society, say ... of a new eye instrument, they have launched a study ... super-human strength could also explain why the 77-year-old sailor has ... like sweetcorn, kale and broccoli are rich in a chemical ...
... in the world may have a less-than-colorful future. Macaws, ... numbers decline in recent decades, and that trend is continuing ... Texas A&M University's Schubot Exotic Bird Center, part of the ... to make sure macaws will not just be photos in ...
... the first-ever computed tomography (CT) evaluation of King Tutankhamun’s ... the ancient pharaoh died. The CT images and results ... meeting of the Radiological Society of North America (RSNA). ... Hospital, Cairo University in Egypt, was part of an ...
Cached Biology News:Why Popeye only has eyes for spinach 2Disappearing nest egg: Researcher studying declining numbers of macaws 2Radiologists attempt to solve mystery of Tut's demise 2